Clinico-microbiological study and antimicrobial drug resistance profile of diabetic foot infections in North India.
暂无分享,去创建一个
[1] V. Jarlier,et al. Diabetic foot ulcer and multidrug‐resistant organisms: risk factors and impact , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[2] V. Mohan,et al. Bacterial etiology of diabetic foot infections in South India. , 2005, European journal of internal medicine.
[3] Ambady Ramachandran,et al. Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients. , 2002, The Journal of the Association of Physicians of India.
[4] K. Itani,et al. Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] A. Boulton,et al. Methicillin‐resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[6] T. Yoshikawa,et al. Infections in diabetes. , 2001, Infectious disease clinics of North America.
[7] S. Kaplan,et al. Foot infections in diabetic patients. Decision and cost-effectiveness analyses. , 1995, JAMA.
[8] Benjamin A Lipsky,et al. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. , 1990, Archives of internal medicine.
[9] V. Ensor,et al. Emergence and dissemination of Enterobacteriaceae with plasmid-mediated CMY-6 and CTX-M-15 beta-lactamases in community in North-India , 2009 .
[10] B. Murray. New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. , 1991, The Journal of infectious diseases.
[11] A. T. Willis. Clostridia of Wound Infection , 1969 .
[12] Marley Ds. Decision and cost-effectiveness analysis. , 1990 .
[13] K. Scher,et al. The septic foot in patients with diabetes. , 1988, Surgery.
[14] M. Toleman,et al. Comment on: Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals. , 2007, The Journal of antimicrobial chemotherapy.
[15] V. Ensor,et al. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals. , 2006, The Journal of antimicrobial chemotherapy.
[16] N. Raja,et al. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases. , 2007, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[17] D. Armstrong,et al. Advances in the treatment of diabetic foot infections. , 2004, Diabetes technology & therapeutics.
[18] Benjamin A Lipsky,et al. Principles and practice of antibiotic therapy of diabetic foot infections , 2000, Diabetes/metabolism research and reviews.
[19] O. Kassim,et al. Characterization of bacterial isolates from diabetic foot infections in Ile-Ife, Southwestern Nigeria , 2006 .
[20] N. Schaper,et al. The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb , 2001, Diabetic medicine : a journal of the British Diabetic Association.
[21] R. Moellering,et al. Antimicrobial-drug resistance. , 1996, The New England journal of medicine.
[22] K. Kapila,et al. Comparison of cefoxitin disc diffusion test, oxacillin screen agar, and PCR for mecA gene for detection of MRSA. , 2009, Indian journal of medical microbiology.
[23] E. Goldstein,et al. Diabetic Foot Infections: Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases , 1996, Diabetes Care.
[24] D. Armstrong,et al. Who is at risk for diabetic foot ulceration? , 1998, Clinics in podiatric medicine and surgery.
[25] P. M. L. Quesne,et al. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. , 1988, The New England journal of medicine.
[26] A. Boulton,et al. CHAPTER 24 – DIABETIC FOOT PROBLEMS AND THEIR MANAGEMENT AROUND THE WORLD , 2008 .
[27] B. Wiedemann. Plasmid-mediated extended spectrum beta-lactamases* , 1992 .
[28] W. F. Todd,et al. 1995 William J. Stickel Bronze Award. Prevalence of mixed infections in the diabetic pedal wound. A retrospective review of 112 infections. , 1995, Journal of the American Podiatric Medical Association.
[29] K. Plaisance,et al. MRSA colonization and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers. , 2001, The Journal of hospital infection.
[30] M. Adil,et al. Comparison of beta-lactamase genes in clinical and food bacterial isolates in India. , 2009, Journal of infection in developing countries.
[31] Jesse A Berlin,et al. Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing. , 2002, Diabetes care.
[32] A. Boulton,et al. The diabetic foot. , 2007, Clinics in dermatology.
[33] Benjamin A Lipsky,et al. Diagnosis and treatment of diabetic foot infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] M. Edmonds,et al. The use of antibiotics in the diabetic foot. , 2004, American journal of surgery.
[35] James S. M. Tan. Foot Infections in diabetic patients , 2004, Current infectious disease reports.
[36] J. Bartlett,et al. Aerobic and Anaerobic Bacteria in Diabetic Foot Ulcers , 1976 .
[37] H. Khan,et al. In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase. , 2007, The Journal of antimicrobial chemotherapy.
[38] Y. Ramot,et al. Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[39] A. Karchmer,et al. Infections in patients with diabetes mellitus. , 1999, The New England journal of medicine.
[40] D. Gerding. Foot infections in diabetic patients: the role of anaerobes. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[41] J. E. Mccartney,et al. Mackie & McCartney practical medical microbiology , 1996 .
[42] Robert A. Bonomo,et al. Extended-Spectrum (cid:2) -Lactamases: a Clinical Update , 2005 .
[43] B. Appalaraju,et al. Extended spectrum -lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility pattern in a tertiary care hospital. , 2004, Indian journal of medical microbiology.